Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies.

MLA

Winiarska, Magdalena, et al. “Inhibitors of SRC Kinases Impair Antitumor Activity of Anti-CD20 Monoclonal Antibodies.” MAbs, vol. 6, no. 5, 2014, pp. 1300–13. EBSCOhost, https://doi.org/10.4161/mabs.32106.

APA

Winiarska, M., Bojarczuk, K., Pyrzynska, B., Bil, J., Siernicka, M., Dwojak, M., Bobrowicz, M., Miazek, N., Zapala, P., Zagozdzon, A., Krol, M., Syta, A., Podszywalow-Bartnicka, P., Pilch, Z., Dabrowska-Iwanicka, A., Juszczynski, P., Efremov, D. G., Slabicki, M., Zenz, T., … Golab, J. (2014). Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies. MAbs, 6(5), 1300–1313. https://doi.org/10.4161/mabs.32106

Chicago

Winiarska, Magdalena, Kamil Bojarczuk, Beata Pyrzynska, Jacek Bil, Marta Siernicka, Michal Dwojak, Malgorzata Bobrowicz, et al. 2014. “Inhibitors of SRC Kinases Impair Antitumor Activity of Anti-CD20 Monoclonal Antibodies.” MAbs 6 (5): 1300–1313. doi:10.4161/mabs.32106.